Psychedelic drugs to treat depression
Researchers are exploring the science of psychedelic drugs as a potential treatment for depression. How effective could they be, and what are the regulatory and legal challenges in their use?

Genome editing creates the possibility of making more precise alterations in the DNA of food crop plants than existing approaches. This POSTnote: describes genome editing technology; identifies which food crops are currently undergoing editing and why; describes the regulation and registration of genome-edited food crops; discusses issues around trade; and describes stakeholder views about the technology.
Genome edited food crops (310 KB , PDF)
Genome editing encompasses a variety of techniques that add, remove, or replace DNA at targeted locations within the genetic code of living cells (the genome). The UK regulates all genome-edited organisms as Genetically Modified Organisms (GMOs): “An organism…in which the genetic material has been altered in a way that does not occur naturally by mating and/or natural recombination”. The UK Government, following their recent consultation on the regulation of genetic technologies in 2021, has outlined a plan to change regulation for certain genome-edited plants in two stages: first to exempt them from GMO field trial regulation in England, and then from the regulatory definition of a GMO. In April 2021, the European Commission also questioned whether the EU’s regulatory framework for GMOs was ‘fit for purpose’ in the face of new technologies. This was based on genome editing (and other genetic technologies) producing plants whose final genome does not contain foreign DNA and are indistinguishable from plants that could be developed by conventional breeding or could occur by nature.
Experts across government, academia and industry largely agree that genome editing could help breeders enhance crops. Genome editing can introduce small changes in the DNA sequences of specific genes known to affect traits of interest to achieve, with greater accuracy and efficiency, the desired genetic outcome of breeding techniques. However, other commentators do not agree that proposed benefits will be likely realised. Mutations are more likely to occur by nature and conventional breeding, but unintended sequence alterations might occur during genome editing. If they result in a safety concern, these lines will not be commercialised. Proponents of genome editing view it as just another tool for crop improvement. Others have highlighted concerns about over-hyping the technology, and have questioned whether the proposed timelines for benefits will be delivered. Public acceptance, in terms of potential risks and benefits, emphasise the importance of traceability, transparency and public engagement, impacts on farming and trade.
Key Points
Acknowledgements
POSTnotes are based on literature reviews and interviews with a range of stakeholders and are externally peer reviewed. POST would like to thank interviewees and peer reviewers for kindly giving up their time during the preparation of this briefing, including:
Members of the POST board*
Department for Environment, Food & Rural Affairs (Defra)*
Professor Gideon Henderson, Defra*
Professor Robin May, Food Standards Agency (FSA)*
Ruth Willis, FSA*
Dr Julian Braybrook, Laboratory of the Government Chemist (LGC)*
Dr Malcolm Burns, LGC*
Selvarani Elahi, LGC*
Mark Buckingham, Agricultural Biotechnology Council (ABC)
Samantha Brooke, British Society of Plant Breeders (BSPB)
Dr Richard Harrison, National Institute of Agricultural Botany (NIAB)
Professor Katherine Denby, University of York*
Professor Lars Østergaard, John Innes Centre (JIC)
Professor Wendy Harwood, JIC*
Dr Penny Hundleby, JIC
Professor Jonathan Jones, The Sainsbury Laboratory (TSL)*
Dr Nicola Patron, Earlham Institute (EI)*
Saskia Hervey, EI
Professor Nigel Halford, Rothamsted Research
Professor Johnathan Napier, Rothamsted Research*
Dr Adrian Ely, University of Sussex*
Dr Gülbanu Kaptan, University of Leeds*
Professor Guy Poppy, University of Southampton
Professor Richard Flavell, International Wheat Yield Partnership
Dr Szabolcs Ruthner, International Seed Federation
Pat Thomas, Beyond GM
Lawrence Woodward, Beyond GM
Dr Helen Wallace, GeneWatchUK*
* denotes people and organisations who acted as external reviewers of the briefing
Genome edited food crops (310 KB , PDF)
Researchers are exploring the science of psychedelic drugs as a potential treatment for depression. How effective could they be, and what are the regulatory and legal challenges in their use?
This briefing outlines what is known about the factors that shape gender incongruence and gender dysphoria. The impact on the NHS from increased referrals for gender identity care is discussed.
This POSTnote summarises child food insecurity and Free School Meal initiatives in England, highlighting relevant research evidence and stakeholder perspectives.